Lorazepam for the Prevention of Recurrent Seizures Related to Alcohol
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND METHODS: Alcohol abuse is one of the most common causes of seizures in adults. In a randomized, double-blind study, we compared lorazepam with placebo for the prevention of recurrent seizures related to alcohol. Over a 21-month period, we studied consecutive patients with chronic alcohol abuse who were at least 21 years of age and who presented to the emergency departments of two hospitals in Boston after a witnessed, generalized seizure. The patients were randomly assigned to receive either 2 mg of lorazepam in 2 ml of normal saline or 4 ml of normal saline intravenously and then observed for six hours. The primary end point was the occurrence of a second seizure during the observation period. RESULTS: Of the 229 patients who were initially evaluated, 186 met the entry criteria. In the lorazepam group, 3 of 100 patients (3 percent) had a second seizure, as compared with 21 of 86 patients (24 percent) in the placebo group (odds ratio for seizure with the use of placebo, 10.4; 95 percent confidence interval, 3.6 to 30.2; P<0.001). Forty-two percent of the placebo group were admitted to the hospital, as compared with 29 percent of the lorazepam group (odds ratio for admission, 2.1; 95 percent confidence interval, 1.1 to 4.0; P=0.02). Seven patients in the placebo group and one in the lorazepam group were transported to an emergency department in Boston with a second seizure within 48 hours after hospital discharge. CONCLUSIONS: Treatment with intravenous lorazepam is associated with a significant reduction in the risk of recurrent seizures related to alcohol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mayo-Smith, M. F. (1997) · JAMA · doi:10.1001/jama.278.2.144 · Cited by 434
Double-blind study of lorazepam and diazepam in status epilepticus
Leppik, L. E. (1983) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1983.03330350028021 · Cited by 354
Cited by
Temkin, N. R. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.28900.x · Cited by 448
The alcohol withdrawal syndrome
McKeon, A., Frye, M. A., & Delanty, N. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.128322 · Cited by 269
Rosenson, J., Clements, C., Simon, B., Vieaux, J., Graffman, S., Vahidnia, F., Cisse, B., Lam, J., & Alter, H. (2013) · The Journal of Emergency Medicine · doi:10.1016/j.jemermed.2012.07.056 · Cited by 162
Clinical management of alcohol withdrawal: A systematic review
Bharadwaj, B., & Kattimani, S. (2013) · Industrial Psychiatry Journal · doi:10.4103/0972-6748.132914 · Cited by 154
“[28] Lorazepam is more effective than diazepam in preventing seizure recurrence .”
Alcohol Withdrawal Syndrome: Benzodiazepines and Beyond
Sachdeva, A. (2015) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2015/13407.6538 · Cited by 141
Metadata
- Authors
- D'Onofrio, G., Rathlev, N. K., Ulrich, A. S., Fish, S. S., & Freedland, E. S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1999-03-25
- Volume
- 340
- Issue
- 12
- Pages
- 915-919
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2172232211
- Cited by
- 130
- References
- 2
- FWCI
- 4.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lorazepam for the Prevention of Recurrent Seizures Related to Alcohol. https://app.cochat.ai/papers/10.1056/nejm199903253401203
- The paper
- D'Onofrio, G., Rathlev, N. K., Ulrich, A. S., Fish, S. S., & Freedland, E. S. (1999). Lorazepam for the Prevention of Recurrent Seizures Related to Alcohol. New England Journal of Medicine. https://doi.org/10.1056/nejm199903253401203
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.